标题
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
作者
关键词
-
出版物
Biomedicines
Volume 9, Issue 3, Pages 324
出版商
MDPI AG
发表日期
2021-03-23
DOI
10.3390/biomedicines9030324
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- How did lomustine become standard of care in recurrent glioblastoma?
- (2020) Michael Weller et al. CANCER TREATMENT REVIEWS
- 5-ALA and FDA approval for glioma surgery
- (2019) Constantinos G. Hadjipanayis et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma in Elderly Patients: Current Management and Future Perspectives
- (2019) Giuseppe Minniti et al. Cancers
- Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
- (2019) Hongqing Zhuang et al. Molecular Cancer
- Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
- (2019) Makoto Ohno et al. Radiation Oncology
- Acceptance and compliance of TTFields treatment among high grade glioma patients
- (2018) Julia Onken et al. JOURNAL OF NEURO-ONCOLOGY
- The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
- (2018) Alyssa M Vanderbeek et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme
- (2018) Chad A. Glenn et al. World Neurosurgery
- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
- (2018) Martin J. B. Taphoorn et al. JAMA Oncology
- Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
- (2018) Farasat Kazmi et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
- (2017) Enshan Feng et al. EUROPEAN NEUROLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of bevacizumab treatment for refractory brain edema
- (2017) Xiangying Meng et al. MEDICINE
- Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
- (2017) Deborah T. Blumenthal et al. NEURO-ONCOLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies
- (2017) Mengnan He et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel
- (2015) Rachel Grossman et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
- (2015) D. T. Blumenthal et al. JOURNAL OF NEURO-ONCOLOGY
- What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
- (2015) Costas G. Hadjipanayis et al. NEUROSURGERY
- Gradient of Apparent Diffusion Coefficient Values in Peritumoral Edema Helps in Differentiation of Glioblastoma From Solitary Metastatic Lesions
- (2014) Pierre Lemercier et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
- (2014) An-an Yin et al. PLoS One
- The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
- (2014) Hans Skovgaard Poulsen et al. Cancer Management and Research
- Second surgery for recurrent glioblastoma: advantages and pitfalls
- (2013) Alba A Brandes et al. Expert Review of Anticancer Therapy
- The role of Gliadel wafers in the treatment of high-grade gliomas
- (2013) Amade Bregy et al. Expert Review of Anticancer Therapy
- Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis
- (2013) Samuel T. Chao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
- (2013) Kaisorn L. Chaichana et al. NEURO-ONCOLOGY
- Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study
- (2013) Dariusz Szczepanek et al. Neurologia i Neurochirurgia Polska
- Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?
- (2012) M Hingorani et al. BRITISH JOURNAL OF RADIOLOGY
- Impact of extent of resection for recurrent glioblastoma on overall survival
- (2012) Orin Bloch et al. JOURNAL OF NEUROSURGERY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Carboplatin and bevacizumab for recurrent malignant glioma
- (2012) MACIEJ M. MRUGALA et al. Oncology Letters
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- (2010) Michael Brada et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Applications of a Peptide-Based Vaccine for Glioblastoma
- (2009) Charles W. Kanaly et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience
- (2008) Frank J. Attenello et al. ANNALS OF SURGICAL ONCOLOGY
- Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
- (2008) Matthew J. McGirt et al. JOURNAL OF NEUROSURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now